A novel DNA-binding protein, HS2NF5, interacts with a functionally important sequence of the human beta-globin locus control region.

The Journal of Biological Chemistry
L T Lam, E H Bresnick

Abstract

We have identified a previously unreported DNA-binding protein, HS2NF5, which interacts with a conserved sequence within hypersensitive site II (HS2) of the human beta-globin locus control region. A minimal DNA recognition sequence of TGTTCTCA was defined. The binding site for HS2NF5 overlaps an E box, which is a preferred recognition site in vitro for the erythroid-specific transcription factor TAL1 (SCL). No evidence for TAL1 (SCL) binding was found using nuclear extracts from K562 and MEL erythroleukemia cells. Mutations that prevent HS2NF5 binding reduce the enhancer activity of HS2 by 40 and 38% in transient and stable transfection assays, respectively. Analytical gel filtration and velocity centrifugation studies revealed a Stokes' radius of 23.0 A and an s20,w of 3.45 for HS2NF5. Based on these parameters, a native molecular mass of 34,679 Da was calculated. An ultraviolet light cross-linking assay was used to cross-link HS2NF5 to a minimal oligonucleotide. The cross-linking results are consistent with a protein of 33,396-38,309 Da. We propose that HS2NF5 is a novel DNA-binding protein that modulates the transcriptional activation property of the beta-globin locus control region.

References

Mar 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·J J CaterinaT M Townes
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·W C ForresterM Groudine
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D TuanI M London
Aug 1, 1995·Molecular and Cellular Biology·K J Kotkow, S H Orkin
Jul 28, 1995·The Journal of Biological Chemistry·J ListerM H Baron
May 12, 1995·The Journal of Biological Chemistry·K S PrasadS J Brandt
Jan 1, 1993·Cold Spring Harbor Symposia on Quantitative Biology·D ClarkG Felsenfeld
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·E H Bresnick, G Felsenfeld
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·H L HsuR Baer
Feb 1, 1994·Molecular and Cellular Biology·H L HsuR Baer
Dec 15, 1995·Cell·D J MangelsdorfR M Evans

❮ Previous
Next ❯

Citations

Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·E H Bresnick, L Tze
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·W K VersawE H Bresnick
Jun 5, 2001·Journal of Cellular Biochemistry. Supplement·E H BresnickJ Norton
Dec 12, 2001·The Journal of Biological Chemistry·Jianlin ChuEmery H Bresnick
Jun 11, 1998·The Journal of Biological Chemistry·K P AndersonJ B Lingrel
Sep 27, 2002·Experimental Biology and Medicine·Susanna HarjuKenneth R Peterson

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.